Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02097810 |
|---|---|
| Brief Title: | Study of Oral RXDX-101 in Adult Patients With Locally Advanced or Metastatic Cancer Targeting NTRK1, NTRK2, NTRK3, ROS1, or ALK Molecular Alterations. (STARTRK-1) |
| First Submitted : | March 21, 2014 |
| First Submitted that Met QC Criteria : | March 24, 2014 |
| First Posted : | March 27, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 7, 2021 |
| Last Update Posted : | June 9, 2021 |